CORRESPONDENCE
Comment on EAACI guideline: Anaphylaxis (2021 update)
Stefano Miceli Sopo,
Corresponding Author
Stefano Miceli Sopo
Pediatric Allergy Unit, Pediatrics Section, Department of Life Sciences and Public Health, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Correspondence
Stefano Miceli Sopo, Pediatric Allergy Unit, Pediatrics Section, Department of Life Sciences and Public Health, Policlinico Gemelli University Foundation IRCCS, Catholic University of Sacred Heart, Rome, Italy.
Email: [email protected]
Search for more papers by this author Dario Sinatti,
Dario Sinatti
Pediatric Allergy Unit, Pediatrics Section, Department of Life Sciences and Public Health, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Search for more papers by this author Francesco Mastellone,
Francesco Mastellone
Department of Life Sciences and Public Health, Post-Graduate School of Pediatrics, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Search for more papers by this author Giulia Bersani,
Giulia Bersani
Pediatric Allergy Unit, Pediatrics Section, Department of Life Sciences and Public Health, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Search for more papers by this author Mariannita Gelsomino,
Mariannita Gelsomino
Department of Life Sciences and Public Health, Post-Graduate School of Pediatrics, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Search for more papers by this author
Stefano Miceli Sopo,
Corresponding Author
Stefano Miceli Sopo
Pediatric Allergy Unit, Pediatrics Section, Department of Life Sciences and Public Health, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Correspondence
Stefano Miceli Sopo, Pediatric Allergy Unit, Pediatrics Section, Department of Life Sciences and Public Health, Policlinico Gemelli University Foundation IRCCS, Catholic University of Sacred Heart, Rome, Italy.
Email: [email protected]
Search for more papers by this author Dario Sinatti,
Dario Sinatti
Pediatric Allergy Unit, Pediatrics Section, Department of Life Sciences and Public Health, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Search for more papers by this author Francesco Mastellone,
Francesco Mastellone
Department of Life Sciences and Public Health, Post-Graduate School of Pediatrics, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Search for more papers by this author Giulia Bersani,
Giulia Bersani
Pediatric Allergy Unit, Pediatrics Section, Department of Life Sciences and Public Health, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Search for more papers by this author Mariannita Gelsomino,
Mariannita Gelsomino
Department of Life Sciences and Public Health, Post-Graduate School of Pediatrics, Policlinico Gemelli Universitary Foundation IRCCS, Catholic University of Sacre Hearth, Rome, Italy
Search for more papers by this author
First published: 30 June 2022
No abstract is available for this article.
CONFLICT OF INTEREST
The authors declare that they have no conflict of interests to disclose in relation to this paper.
REFERENCES
- 1Muraro A, Worm M, Alviani C, et al. EAACI guideline: Anaphylaxis (2021 update). Allergy. 2022; 77(2): 357-377.
- 2Pajno GB, Fernandez-Rivas M, Arasi S, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018; 73(4): 799-815.
- 3Chu DK, Wood RA, French S, et al. Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety. Lancet. 2019; 393(10187): 2222-2232.
